Currently, there are conflicting, non-evidence-based practice patterns on testosterone replacement therapy. The inconsistencies in the guidelines merely create confusion among the physicians instead of providing clear information.
Although a few cannabinoid drugs have been approved by the Federal Drug Administration (FDA), cannabis has not been approved by the FDA for the treatment of any disease or condition. Therefore, physicians need to know the latest clinical trial information regarding the potential health benefits of cannabis use as well as epidemiologic data regarding potential health risks.
Lung Cancer is the second most common cancer in both men and women (not including skin cancer) and is by far the leading cause of cancer death. Overall, the chance of developing lung cancer is about 1 in 16 in men and 1 in 17 in women.
TRENDING MEDICAL EDUCATION TOPIC: REDUCING LGBTQ+ HEALTHCARE DISPARITIES Sexual and gender minority (SGM) people – which primarily includes members of the lesbian, gay, bisexual, transgender, and […]
TRENDING MEDICAL EDUCATION TOPIC: OPOID USE DISORDER Opioid Use Disorder (OUD) is the chronic use of opioids that causes clinically significant distress or impairment. OUD affects […]